By: Anglia Ruskin University From: medicalxpress.com A model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast cancer patients who would previously have been advised to consider the treatment. The latest version of the PREDICT Breast model , published in npj Breast Cancer and launched this week, …
Breast cancer stage, receptor status may help predict recurrence risk
By: Jennifer Southall From: healio.com Key findings: Researchers observed significant variations in time to first recurrence between receptor-type groups (P < .0001), and stage influenced the time to recurrence within each receptor-type group. Three-quarters of recurrences occurred within 1.92 years of study baseline among patients with triple-negative breast cancer, whereas 75% occurred within 3.05 years of baseline among patients with …
PreludeDx Present Results from PREDICT Study at ASBrS Annual Meeting
Source: Prelude Corporation From: prnewswire.com Prelude Corporation (PreludeDx), a leader in molecular diagnostics and personalized medicine for early stage breast cancer, presented interim results from its large PREDICT study during a poster presentation (Abstract ID: 581643), titled “Interim Analysis of the DCISionRT PREDICT Study: Clinical Utility of a Biologic Signature Predictive of Radiation Therapy (RT) Benefit in Patients with DCIS”, …